Moreover, carvacrol exerts a strong acetylcholinesterase (AChE) inhibitory effect due to the molecule hydroxyl group binding to AChE, causing a loss of function of AChE, thus suggesting a possible application in Alzheimer’s disease treatment [21]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.